Table 1. Concentrations of uNGAL/uCr ratio, bNGAL and sNGAL at different time points.
|
No-AKI (N = 18) |
AKI (N = 7) |
P | |
|---|---|---|---|
| uNGAL/uCr ratio (ng/mg) | |||
| baseline | 1.18 (0.69 – 3.17) | 0.84 (0.61 - 1.31) | 0.380 |
| 4h | 2.25 (1.14 – 4.55) | 1.97 (1,89 - 4.12) | 0.739 |
| 18h | 1.69 (0.91 - 2.47) | 3.20 (2.08 - 5.92) | 0.035 |
| bNGAL (ng/dL) | |||
| baseline | 59 (59 - 74) | 60 (59 – 118) | 0.580 |
| 4h | 64 (59 – 105) | 102 (82 – 144) | 0.101 |
| 18h | 83 (59 – 131) | 164 (127 - 201) | 0.029 |
| sNGAL (ng/dL) | |||
| baseline | 138 (64 – 188) | 125 (80 – 161) | 0.931 |
| 4h | 174 (85 - 215) | 173 (140 – 226) | 0.714 |
| 18h | 137 (98 – 217) | 185 (153 – 226) | 0.429 |
| The results are expressed as median and IQR. P < 0.05 was considered statistically significant. NGAL - neutrophil gelatinase-associated lipocalin. uNGAL - urinary NGAL. bNGAL - whole blood NGAL. sNGAL - serum NGAL. uCr - urinary creatinine. AKI - acute kidney injury. | |||